Clinical Trial Update: Allogeneic CMV-Specific CD19-CAR T Cells Plus CMV-MVA Triplex Vaccine After Matched Related Donor Hematopoietic Cell Transplant for the Treatment of Patients With High-Risk Acute Lymphoblastic Leukemia [EARLY_Phase 1]

View source ↗

Summary

This early-phase clinical trial evaluates the safety and feasibility of combining allogeneic CMV-specific CD19-CAR T cells with the CMV-MVA Triplex Vaccine afte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Allogeneic CMV-Specific CD19-CAR T Cells
• CMV-MVA Triplex Vaccine (CMV-MVA Triplex Vaccine)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Acute Lymphoblastic Leukemia | EARLY_Phase 1 | Status: RECRUITING